Advances in Therapy

, Volume 29, Issue 4, pp 297–311 | Cite as

Definition and Outpatient Management of the Very Low-Birth-Weight Infant With Bronchopulmonary Dysplasia

Open Access
Review

Abstract

Bronchopulmonary dysplasia (BPD), also known as chronic lung disease of prematurity, is the major cause of pulmonary disease in infants. The pathophysiology and management of BPD have evolved over the past four decades as improved neonatal intensive care unit (NICU) modalities have increased survival rates. The likelihood for developing BPD increases with the degree of prematurity and reaches 25–35% in very low-birth-weight and extremely low-birth-weight infants. BPD affects many organ systems, and infants with BPD are at increased risk for rehospitalization and numerous complications following NICU discharge. The management of BPD and medically related problems, particularly during the first 2 years of life, remains a continuing challenge for parents and healthcare providers. It is important that a multidisciplinary team consisting of the neonatologist/attending physician, primary care physician, and other specialized support staff work in concert and meet regularly to provide continuity of care and accurate patient assessments.

Keywords

Bronchopulmonary Dysplasia Chronic Lung Disease of Prematurity Complications Discharge Planning Growth Home Oxygen Therapy Incidence Nutrition Outpatient Management Respiratory Syncytial Virus 

References

  1. 1.
    Allen J, Zwerdling R, Ehrenkranz R, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med. 2003;168:356–396.PubMedCrossRefGoogle Scholar
  2. 2.
    Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946–1955.PubMedCrossRefGoogle Scholar
  3. 3.
    Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr. 2011;23:167–172.PubMedCrossRefGoogle Scholar
  4. 4.
    Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyalinemembrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357–368.PubMedCrossRefGoogle Scholar
  5. 5.
    Bancalari E, Abdenour GE, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr. 1979;95:819–823.PubMedCrossRefGoogle Scholar
  6. 6.
    Bureau of Maternal and Child Health and Resources Development. Guidelines for the care of children with chronic lung disease. Pediatr Pulmonol. 1989;7:3–4.CrossRefGoogle Scholar
  7. 7.
    Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–1729.PubMedGoogle Scholar
  8. 8.
    Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003;8:73–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Langston C, Kida K, Reed M, Thurlbeck WM. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis. 1984;129:607–613.PubMedGoogle Scholar
  10. 10.
    Jobe AH. Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol. 2003;8:9–17.PubMedCrossRefGoogle Scholar
  11. 11.
    Speer CP. Inflammation and bronchopulmonary dysplasia. Semin Neonatol. 2003;8:29–38.PubMedCrossRefGoogle Scholar
  12. 12.
    Bhering CA, Mochdece CC, Moreira ME, Rocco JR, Sant’Anna GM. Bronchopulmonary dysplasia prediction model for 7-day-old infants. J Pediatr. (Rio J). 2007;83:163–170.CrossRefGoogle Scholar
  13. 13.
    Chess PR, D’Angio CT, Pryhuber GS, Maniscalco WM. Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol. 2006;30:171–178.PubMedCrossRefGoogle Scholar
  14. 14.
    Kwinta P, Bik-Multanowski M, Mitkowska Z, et al. Genetic risk factors of bronchopulmonary dysplasia. Pediatr Res. 2008;64:682–688.PubMedCrossRefGoogle Scholar
  15. 15.
    Zhang H, Fang J, Su H, Chen M. Risk factors for bronchopulmonary dysplasia of neonates born at ≤1500 g of birth weight (1999–2009). Pediatr Int. 2011;53:915–920.PubMedCrossRefGoogle Scholar
  16. 16.
    Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114:1305–1311.PubMedCrossRefGoogle Scholar
  17. 17.
    Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am. 1994;41:277–315.PubMedGoogle Scholar
  18. 18.
    Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993–2006. Pediatrics. 2010;126:291–297.PubMedCrossRefGoogle Scholar
  19. 19.
    Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2008. Hyattsville, MD: National Center for Health Statistics; 2010. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_01.pdf. Accessed Mar 17 2012.Google Scholar
  20. 20.
    Fanaro S, Vigi V. Weaning preterm infants: an open issue. J Pediatr Gastroenterol Nutr. 2007;45(Suppl. 3):S204–S209.PubMedGoogle Scholar
  21. 21.
    Chien YH, Tsao PN, Chou HC, Tang JR, Tsou KI. Rehospitalization of extremely-low-birth-weight infants in first 2 years of life. Early Hum Dev. 2002;66:33–40.PubMedCrossRefGoogle Scholar
  22. 22.
    Doyle LW, Ford G, Davis N. Health and hospitalisations after discharge in extremely low birth weight infants. Semin Neonatol. 2003;8:137–145.PubMedCrossRefGoogle Scholar
  23. 23.
    Lamarche-Vadel A, Blondel B, Truffer P, et al. Rehospitalization in infants younger than 29 weeks’ gestation in the EPIPAGE cohort. Acta Paediatr. 2004;93:1340–1345.PubMedCrossRefGoogle Scholar
  24. 24.
    Luu TM, Lefebvre F, Riley P, Infante-Rivard C. Continuing utilisation of specialised health services in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2010;95:F320–F325.PubMedCrossRefGoogle Scholar
  25. 25.
    Smith VC, Zupancic JA, McCormick MC, et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr. 2004;144:799–803.PubMedGoogle Scholar
  26. 26.
    Hintz SR, Kendrick DE, Vohr BR, et al. Community supports after surviving extremely low-birthweight, extremely preterm birth: special outpatient services in early childhood. Arch Pediatr Adolesc Med. 2008;162:748–755.PubMedCrossRefGoogle Scholar
  27. 27.
    American Academy of Pediatrics Committee on Fetus and Newborn. Hospital discharge of the high-risk neonate. Pediatrics. 2008;122:1119–1126.CrossRefGoogle Scholar
  28. 28.
    Bancalari E, Wilson-Costello D, Iben SC. Management of infants with bronchopulmonary dysplasia in North America. Early Hum Dev. 2005;81:171–179.PubMedCrossRefGoogle Scholar
  29. 29.
    Groothuis JR, Louch GK, Van Eman C. Outpatient management of the preterm infant. RT: J Respir Care Prac. 1996:69–73.Google Scholar
  30. 30.
    Vaucher YE. Bronchopulmonary dysplasia: an enduring challenge. Pediatr Rev. 2002;23:349–358.PubMedCrossRefGoogle Scholar
  31. 31.
    MedicalHome.org. Extremely low birth weight NICU graduate. Available at: http://www.medicalhome.org/4Download/cec/elbw.pdf. Accessed Aug 31 2011.
  32. 32.
    Brooten D, Kumar S, Brown LP, et al. A randomized clinical trial of early hospital discharge and home follow-up of very-low-birth-weight infants. N Engl J Med. 1986;315:934–939.PubMedCrossRefGoogle Scholar
  33. 33.
    Powell PJ, Powell CV, Hollis S, Robinson MJ. When will my baby go home? Arch Dis Child. 1992;67:1214–1216.PubMedCrossRefGoogle Scholar
  34. 34.
    Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics. 1997;100:354–359.PubMedCrossRefGoogle Scholar
  35. 35.
    Hintz SR, Bann CM, Ambalavanan N, et al. Predicting time to hospital discharge for extremely preterm infants. Pediatrics. 2010;125:e146–e154.PubMedCrossRefGoogle Scholar
  36. 36.
    Miles MS, Holditch-Davis D, Schwartz TA, Scher M. Depressive symptoms in mothers of prematurely born infants. J Dev Behav Pediatr. 2007;28:36–44.PubMedCrossRefGoogle Scholar
  37. 37.
    Singer LT, Fulton S, Kirchner HL, et al. Longitudinal predictors of maternal stress and coping after very low-birth-weight birth. Arch Pediatr Adolesc Med. 2010;164:518–524.PubMedCrossRefGoogle Scholar
  38. 38.
    Melnyk BM, Crean HF, Feinstein NF, Fairbanks E. Maternal anxiety and depression after a premature infant’s discharge from the neonatal intensive care unit: explanatory effects of the creating opportunities for parent empowerment program. Nurs Res. 2008;57:383–394.PubMedCrossRefGoogle Scholar
  39. 39.
    Koo KY, Kim JE, Lee SM, et al. Effect of severe neonatal morbidities on long term outcome in extremely low birthweight infants. Korean J Pediatr. 2010;53:694–700.PubMedCrossRefGoogle Scholar
  40. 40.
    Galdes-Sebaldt M, Sheller JR, Grogaard J, Stahlman M. Prematurity is associated with abnormal airway function in childhood. Pediatr Pulmonol. 1989;7:259–264.PubMedCrossRefGoogle Scholar
  41. 41.
    Greenough A. Long-term pulmonary outcome in the preterm infant. Neonatology. 2008;93:324–327.PubMedCrossRefGoogle Scholar
  42. 42.
    Brostrom EB, Thunqvist P, Adenfelt G, Borling E, Katz-Salamon M. Obstructive lung disease in children with mild to severe BPD. Respir Med. 2010;104:362–370.PubMedCrossRefGoogle Scholar
  43. 43.
    Hennessy EM, Bracewell MA, Wood N, et al. Respiratory health in pre-school and school age children following extremely preterm birth. Arch Dis Child. 2008;93:1037–1043.PubMedCrossRefGoogle Scholar
  44. 44.
    Majnemer A, Riley P, Shevell M, et al. Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Dev Med Child Neurol. 2000;42:53–60.PubMedGoogle Scholar
  45. 45.
    Huysman WA, de Ridder M, de Bruin NC, et al. Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed. 2003;88:F46–F51.PubMedCrossRefGoogle Scholar
  46. 46.
    Greenough A, Alexander J, Boit P, et al. School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants. Thorax. 2009;64:490–495.PubMedCrossRefGoogle Scholar
  47. 47.
    Mendes TB, Mezzacappa MA, Toro AA, Ribeiro JD. Risk factors for gastroesophageal reflux disease in very low birth weight infants with bronchopulmonary dysplasia. J Pediatr. (Rio J). 2008;84:154–159.CrossRefGoogle Scholar
  48. 48.
    Zanchetta S, Resende LA, Bentlin MR, Rugulo LM, Trindade CE. Conductive hearing loss in children with bronchopulmonary dysplasia: a longitudinal follow-up study in children aged between 6 and 24 months. Early Hum Dev. 2010;86:385–389.PubMedCrossRefGoogle Scholar
  49. 49.
    McCleod G, Simmer K, Benninger H, et al. Preterm infants with chronic lung disease: are protein and energy intakes after discharge sufficient for optimal growth? J Paediatr Child Health. 2011;47:127–133.CrossRefGoogle Scholar
  50. 50.
    Dobbing J, Smart JL. Undernutrition and the developing brain. Br Med Bull. 1974;30:164–168.PubMedGoogle Scholar
  51. 51.
    Mikkola K, Ritari N, Tommiska V, et al. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996–1997. Pediatrics. 2005;116:1391–1400.PubMedCrossRefGoogle Scholar
  52. 52.
    Stathis SL, O’Callaghan M, Harvey J, Rogers Y. Head circumference in ELBW babies is associated with learning difficulties and cognition but not ADHD in the school-aged child. Dev Med Child Neurol. 1999;41:375–380.PubMedCrossRefGoogle Scholar
  53. 53.
    American Academy of Pediatrics. Nutritional needs of the preterm infants. Pediatric Nutrition Handbook. 5th edition: American Academy of Pediatrics; 2004.Google Scholar
  54. 54.
    Children’s Hospitals and Clinics of Minnesota. Patient/Family Education. Formula adjustment. Available at: http://www.childrensmn.org/Manuals/PFS/Nutr/018731.pdf. Accessed Dec 12 2011.
  55. 55.
    Young TE. Nutritional support and bronchopulmonary dysplasia. J Perinatol. 2007;27:S75–S78.CrossRefGoogle Scholar
  56. 56.
    Cooke R, Embleton N, Rigo J, et al. High protein pre-term infant formula: effect on nutrient balance, metabolic status and growth. Pediatr Res. 2006;59:265–270.PubMedCrossRefGoogle Scholar
  57. 57.
    Henriksen C, Haugholt K, Lindgren M, et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics. 2008;121:1137–1145.PubMedCrossRefGoogle Scholar
  58. 58.
    McCormick FM, Henderson G, Fahey T, McGuire W. Multinutrient fortification of human breast milk for preterm infants following hospital discharge. Cochrane Database Syst Rev. 2010:CD004866.Google Scholar
  59. 59.
    Zachariassen G, Faerk J, Grytter C, et al. Nutrient enrichment of mother’s milk and growth of very preterm infants after hospital discharge. Pediatrics. 2011;127:e995–1003.PubMedCrossRefGoogle Scholar
  60. 60.
    Rao R, Georgieff MK. Iron therapy for preterm infants. Clin Perinatol. 2009;36:27–42.PubMedCrossRefGoogle Scholar
  61. 61.
    Groothuis JR, Louch GK. Home care of the neonatal intensive care unit graduate. J Am Acad Phys Assist. 1989;1:353–358.Google Scholar
  62. 62.
    Saari TN, American Academy of Pediatrics Committee on Infectious Diseases. Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 2003;112:193–198.PubMedCrossRefGoogle Scholar
  63. 63.
    Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1128–1132.Google Scholar
  64. 64.
    Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588–598.PubMedCrossRefGoogle Scholar
  65. 65.
    Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988;82:199–203.PubMedGoogle Scholar
  66. 66.
    American Academy of Pediatrics. Respiratory syncytial virus. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th edition. Elk Grove Village, IL: American Academy of Pediatrics; 2009:560–569.Google Scholar
  67. 67.
    Walsh MC, Szefler S, Davis J, et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics. 2006;117:S52–S56.PubMedGoogle Scholar
  68. 68.
    Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 2002;109:330–338.CrossRefGoogle Scholar
  69. 69.
    Pantalitschka T, Poets CF. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia. Pediatr Pulmonol. 2008;41:703–708.CrossRefGoogle Scholar
  70. 70.
    De Boeck K, Smith J, Van Lierde S, Devlieger H. Response to bronchodilators in clinically stable 1-year-old patients with bronchopulmonary dysplasia. Eur J Pediatr. 1998;157:75–79.PubMedCrossRefGoogle Scholar
  71. 71.
    Christou H, Brodsky D. Lung injury and bronchopulmonary dysplasia in newborn infants. J Intensive Care Med. 2005;20:76–87.PubMedCrossRefGoogle Scholar
  72. 72.
    Groothuis JR, Rosenberg AA. Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia. Am J Dis Child. 1987;141:992–995.PubMedGoogle Scholar
  73. 73.
    Ellsbury DL, Acarregui MJ, McGuinness GA, Eastman DL, Klein JM. Controversy surrounding the use of home oxygen for premature infants with bronchopulmonary dysplasia. J Perinatol. 2004;24:36–40.PubMedCrossRefGoogle Scholar
  74. 74.
    Greenough A, Alexander J, Burgess S, et al. Preschool healthcare utilisation related to home oxygen status. Arch Dis Child Fetal Neonatal Ed. 2006;91:F337–F341.PubMedCrossRefGoogle Scholar
  75. 75.
    Koops BL, Abman SH, Accurso FJ. Outpatient management and follow-up of bronchopulmonary dysplasia. Clin Perinatol. 1984;11:101–122.PubMedGoogle Scholar
  76. 76.
    Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOPROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000;105:295–310.CrossRefGoogle Scholar
  77. 77.
    Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349:959–967.PubMedCrossRefGoogle Scholar
  78. 78.
    Halbower AC, McGrath SA. Home oxygen therapy: the jury is still in session. J Perinatol. 2004;24:59–61.PubMedCrossRefGoogle Scholar
  79. 79.
    Singer L, Yamashita T, Lilien L, Collin M, Baley J. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics. 1997;100:987–993.PubMedCrossRefGoogle Scholar
  80. 80.
    Stahlman MT. Medical complications in premature infants: is treatment enough? N Engl J Med. 1989;320:1551–1553.PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2012

Authors and Affiliations

  1. 1.One MedImmune WayGaithersburgUSA

Personalised recommendations